Literature DB >> 9048672

Evolution of epilepsy and EEG findings in Angelman syndrome.

L A Laan1, W O Renier, W F Arts, I M Buntinx, I J vd Burgt, H Stroink, J Beuten, K H Zwinderman, J G van Dijk, O F Brouwer.   

Abstract

PURPOSE: To evaluate the evolution of epileptic seizures and EEG features in a large group of patients with Angelman syndrome (AS).
METHODS: Thirty-six patients with AS with a proven chromosome 15q11-13 deletion were retrospectively analyzed with regard to their epilepsy and EEG findings by examination of patient files and EEGs. AIJ EEGs were reviewed by one of the authors. A logistic regression model, with a follow-up from 1 to 39 years (mean, 15 years), was used for statistical analysis.
RESULTS: Epileptic seizures had occurred in 30 (83%) patients. In 43% of them, the initial symptoms of epilepsy were febrile convulsions in infancy. In childhood, epilepsy could start with almost any type of seizure. Atypical absences and myoclonic seizures prevailed in adulthood. Epileptic seizures were present in 92% of the adult patients. The most typical EEG findings were rhythmic triphasic delta waves of high amplitude with a maximum over the frontal regions, identified in 99 (66%) of 150 EEGs, and continuously or intermittently, in 30 (83%) of 36 patients with AS. In 47% it was present even before a clinical diagnosis of AS was considered. High-amplitude rhythmic 4-6/s slow activity, seen in 44 (29%) of 150 EEGs, was not present after the age of 12 years.
CONCLUSIONS: In contrast to previous reports suggesting a decreasing frequency of epileptic seizures with age, we found that 92% of the adult patients with AS continued to have epileptic seizures. The most typical EEG finding in AS, in both children and adults, was the presence of frontal triphasic delta waves. In mentally retarded patients, this EEG pattern should point the physician in the direction of AS.

Entities:  

Mesh:

Year:  1997        PMID: 9048672     DOI: 10.1111/j.1528-1157.1997.tb01097.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  26 in total

Review 1.  Angelman syndrome (AS, MIM 105830).

Authors:  Griet Van Buggenhout; Jean-Pierre Fryns
Journal:  Eur J Hum Genet       Date:  2009-05-20       Impact factor: 4.246

2.  Revisiting epilepsy and the electroencephalogram patterns in Angelman syndrome.

Authors:  Marcio Leyser; Patricia Sola Penna; Alexandre Cardozo de Almeida; Marcio Moacyr Vasconcelos; Osvaldo J M Nascimento
Journal:  Neurol Sci       Date:  2014-01-07       Impact factor: 3.307

3.  Angelman syndrome: Mutations influence features in early childhood.

Authors:  Wen-Hann Tan; Carlos A Bacino; Steven A Skinner; Irina Anselm; Rene Barbieri-Welge; Astrid Bauer-Carlin; Arthur L Beaudet; Terry Jo Bichell; Jennifer K Gentile; Daniel G Glaze; Lucia T Horowitz; Sanjeev V Kothare; Hye-Seung Lee; Mark P Nespeca; Sarika U Peters; Trilochan Sahoo; Dean Sarco; Susan E Waisbren; Lynne M Bird
Journal:  Am J Med Genet A       Date:  2011-01       Impact factor: 2.802

4.  Parental view of epilepsy in Angelman syndrome: a questionnaire study.

Authors:  M Ruggieri; M A McShane
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

5.  Angelman syndrome in adulthood.

Authors:  Anna M Larson; Julianna E Shinnick; Elias A Shaaya; Elizabeth A Thiele; Ronald L Thibert
Journal:  Am J Med Genet A       Date:  2014-11-26       Impact factor: 2.802

Review 6.  Angelman syndrome: etiology, clinical features, diagnosis, and management of symptoms.

Authors:  Renzo Guerrini; Romeo Carrozzo; Roberta Rinaldi; Paolo Bonanni
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

7.  Ube3a reinstatement mitigates epileptogenesis in Angelman syndrome model mice.

Authors:  Bin Gu; Kelly E Carstens; Matthew C Judson; Katherine A Dalton; Marie Rougié; Ellen P Clark; Serena M Dudek; Benjamin D Philpot
Journal:  J Clin Invest       Date:  2018-11-19       Impact factor: 14.808

8.  SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndrome.

Authors:  Gregor D Gilfillan; Kaja K Selmer; Ingrid Roxrud; Raffaella Smith; Mårten Kyllerman; Kristin Eiklid; Mette Kroken; Morten Mattingsdal; Thore Egeland; Harald Stenmark; Hans Sjøholm; Andres Server; Lena Samuelsson; Arnold Christianson; Patrick Tarpey; Annabel Whibley; Michael R Stratton; P Andrew Futreal; Jon Teague; Sarah Edkins; Jozef Gecz; Gillian Turner; F Lucy Raymond; Charles Schwartz; Roger E Stevenson; Dag E Undlien; Petter Strømme
Journal:  Am J Hum Genet       Date:  2008-03-13       Impact factor: 11.025

Review 9.  Epilepsy in patients with Angelman syndrome.

Authors:  Agata Fiumara; Annarita Pittalà; Mariadonatella Cocuzza; Giovanni Sorge
Journal:  Ital J Pediatr       Date:  2010-04-16       Impact factor: 2.638

10.  GABAergic Neuron-Specific Loss of Ube3a Causes Angelman Syndrome-Like EEG Abnormalities and Enhances Seizure Susceptibility.

Authors:  Matthew C Judson; Michael L Wallace; Michael S Sidorov; Alain C Burette; Bin Gu; Geeske M van Woerden; Ian F King; Ji Eun Han; Mark J Zylka; Ype Elgersma; Richard J Weinberg; Benjamin D Philpot
Journal:  Neuron       Date:  2016-03-24       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.